Drew20 (1979) | Appropriate for gestational age infants, birth weight <1500 g, not needing assisted ventilation | Nasojejunal: n = 32 | Until achieving an enteral intake of 200 ml/kg/day | Growth |
Nasogastric: n = 34 | Adverse events |
Laing21 (1986) | Appropriate for gestational age infants, birth weight <1500 g | Continuous nasoduodenal: n = 45 | Seven weeks | Growth |
Intermittent nasogastric: n = 35 | | Adverse events |
Macdonald22 (1992) | Formula fed infants, birth weight <1400 g | Continuous nasoduodenal: n = 15 | Until weight ⩾1600 g | Growth |
Bolus nasogastric: n = 15 | | Time to full enteral feeding |
Continuous nasogastric: n = 13 | | Adverse events |
Pereira23 (1981) | Infants, birth weight <1700 g or gestation <33 weeks | Continuous nasojejunal: n = 26 | Until breast feeding | Growth |
Intermittent nasogastric: n = 27 | | Adverse events |
Roy24 (1975) | Appropriate for gestational age infants, birth weight <1500 g, not needing assisted ventilation | Continuous nasojejunal: n = 12 | Seven days | Growth |
| Intermittent nasogastric: n = 9 | | |
Van Caillie25 (1975) | Preterm infants, birth weight <1300 g | Continuous nasoduodenal: n = 6 | 40 days | Growth |
Continuous nasogastric n = 5 | | Adverse events |
Wells26 (1975) | Preterm infants, birth weight <1500 g | Continuous nasojejunal: n = 1 | 21 days | Growth |
Intermittent nasogastric: n = 11 | | Adverse events |
Whitfield27 (1982) | Appropriate for gestational age infants, birth weight 1000–1500 g | Continuous nasojejunal: n = 28 | Until weight ⩾1500 g | Growth (until six months old) |
Intermittent nasogastric: n = 16 | | Adverse events |